LIGAND PHARMACEUTICALS INCORPORATED Payments of Merger Related Costs, Financing Activities
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) reported Payments of Merger Related Costs, Financing Activities of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2025-02-28
- LIGAND PHARMACEUTICALS INCORPORATED payments of merger related costs, financing activities for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED payments of merger related costs, financing activities for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED payments of merger related costs, financing activities for the quarter ending 2022-12-31 was $2.63M.
- LIGAND PHARMACEUTICALS INCORPORATED payments of merger related costs, financing activities for the quarter ending 2022-09-30 was $3.96M.
- LIGAND PHARMACEUTICALS INCORPORATED payments of merger related costs, financing activities for fiscal 2024 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED payments of merger related costs, financing activities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED payments of merger related costs, financing activities for fiscal 2022 was $6.80M.
- LIGAND PHARMACEUTICALS INCORPORATED payments of merger related costs, financing activities for fiscal 2021 was $0.00.
| Period end | Payments of Merger Related Costs, Financing Activities 3 month | Payments of Merger Related Costs, Financing Activities 6 month | Payments of Merger Related Costs, Financing Activities 9 month | Payments of Merger Related Costs, Financing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | |||
| 2022-12-31 | $2.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $6.59M derived: sum of 2 quarters · filed 2025-02-28 | $6.80M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $3.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $4.17M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $206.00K 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-28 |